Scholars@Duke

• Expertise
• 

  Subject Headings

  • Allergy and Immunology
  • Immunological adjuvants
  • Vaccines
• Research
• 

  Selected Grants

  • Bacteriophage virus-like particle vaccines for fentanyl and heroin overdose awarded by University of New Mexico 2021 - 2024
  • Adjuvant Comparison for Peanut Allergy Immunotherapy awarded by National Institutes of Health 2022 - 2023
  • Vaccine Adjuvant Discovery Program awarded by University of Montana 2019 - 2022
  • Design and Engineering of VesiVax HIV Immunogen Formulations awarded by Molecular Express, Inc. 2020 - 2021
  • Evaluation of Conjugated VesiVax Formulations for HIV Vaccines awarded by Molecular Express, Inc. 2020 - 2021
  • Evaluation of VesiVax Adjuvant Formulations for HIV Vaccines awarded by Molecular Express, Inc. 2019 - 2021
  • Adjuvant Discovery Program (Option #3) awarded by National Institutes of Health 2014 - 2020
  • Adjuvant Discovery Program (Option #2) awarded by National Institutes of Health 2014 - 2019
  • Development of a Peanut Allergy Immunotherapy awarded by Molecular Express, Inc. 2017 - 2019
  • Delivery of Self-Replicating HIV Vaccines Using In Vitro Reconstituted Virus-Like Particles awarded by Molecular Express, Inc. 2018
  • Adjuvant Discovery Program (Option #1) awarded by National Institutes of Health 2014 - 2017
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Johnson-Weaver, Brandi T., Susan McRitchie, Kelly A. Mercier, Wimal Pathmasiri, Susan J. Sumner, Cliburn Chan, Dori Germolec, Michael Kulis, A Wesley Burks, and Herman F. Staats. “Effect of endotoxin and alum adjuvant vaccine on peanut allergy.” J Allergy Clin Immunol 141, no. 2 (February 2018): 791-794.e8. https://doi.org/10.1016/j.jaci.2017.07.043.
       Full Text  Link to Item
    • Roggelin, Louise, Christof D. Vinnemeier, Johanna Fischer-Herr, Brandi T. Johnson-Weaver, Thierry Rolling, Gerd D. Burchard, Herman F. Staats, and Jakob P. Cramer. “Serological response following re-vaccination with Salmonella typhi Vi-capsular polysaccharide vaccines in healthy adult travellers.” Vaccine 33, no. 33 (August 7, 2015): 4141–45. https://doi.org/10.1016/j.vaccine.2015.05.080.
       Full Text  Link to Item
    • Gwinn, William M., Brandi T. Johnson, Shaun M. Kirwan, Ashley E. Sobel, Soman N. Abraham, Michael D. Gunn, and Herman F. Staats. “A comparison of non-toxin vaccine adjuvants for their ability to enhance the immunogenicity of nasally-administered anthrax recombinant protective antigen.” Vaccine 31, no. 11 (March 1, 2013): 1480–89. https://doi.org/10.1016/j.vaccine.2013.01.012.
       Full Text  Link to Item
    • Thompson, Afton L., Brandi T. Johnson, Gregory D. Sempowski, Michael D. Gunn, Baidong Hou, Anthony L. DeFranco, and Herman F. Staats. “Maximal adjuvant activity of nasally delivered IL-1α requires adjuvant-responsive CD11c(+) cells and does not correlate with adjuvant-induced in vivo cytokine production.” J Immunol 188, no. 6 (March 15, 2012): 2834–46. https://doi.org/10.4049/jimmunol.1100254.
       Full Text  Link to Item

  • Book Sections

    • Johnson-Weaver, Brandi, Soman Abraham, and Herman Staats. “Innate Immunity based Mucosal Modulators and Adjuvants.” In Mucosal Vaccines, edited by Hiroshi Kiyono and David Pascual, 167–83. Academic Press, 2020. https://doi.org/10.1016/C2016-0-00017-7.
       Full Text  Link to Item
    • Choi, Hae Woong, Brandi Johnson-Weaver, Herman Staats, and Soman Abraham. “Mast Cells For the Control of Mucosal Immunity.” In Mucosal Vaccines Innovation for Preventing Infectious Diseases, edited by Hiroshi Kiyono and David Pascual. Academic Press, 2019.
       Link to Item
    • Johnson-Weaver, Brandi, Soman Abraham, and Herman Staats. “Innate Immunity-Based Mucosal Modulators and Adjuvants.” In Mucosal Vaccines Innovation for Preventing Infectious Diseases, edited by Hiroshi Kiyono and David Pascual. Academic Press, 2019.
       Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.